NCT06104579

Brief Summary

The Catalan Cancer Plan (CCP) undertakes periodic audits of cancer treatment outcomes, including organ/space surgical site infections (O/S-SSI) rates, while the Catalan Healthcare-associated Infections Surveillance Programme (VINCat) carries out standardized prospective surveillance of surgical site infections (SSIs) in colorectal surgery. This cohort study aimed to assess the concordance between these two monitoring systems for O/S-SSI following primary rectal cancer surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,367

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
6.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
Last Updated

May 31, 2024

Status Verified

October 1, 2023

Enrollment Period

6 years

First QC Date

October 23, 2023

Last Update Submit

May 29, 2024

Conditions

Keywords

Surgical Site InfectionRectal cancerRectal SurgeryDatabases concordance

Outcome Measures

Primary Outcomes (1)

  • Rate of Organ-space surgical site infection

    As described by the Centers for Disease Control: an infection occurring within 30 days of the surgical procedure and involves any part of the body deeper than the fascial/muscle layers that is opened or manipulated during surgery. In addition, the patient must present at least one of the following associated events: a purulent drainage from a drain placed into the organ/space

    30 days

Study Arms (2)

Patients operated on rectal cancer, included in the Catalan Cancer Registry

Patients operated on rectal cancer, included in two compulsory audits of the Catalan Cancer registry, and who suffered an organ-space surgical infection.

Other: Person-level linkage of both databases looking for concordance in the diagnosis of organ-space surgical site infection

Patients operated on rectal surgery, included in the Catalan Infection Surveillance Program

Patients included in the voluntary Catalan Infection Surveillance Program, and followed for 30 days postoperatively, and who suffered an organ-space surgical infection.

Other: Person-level linkage of both databases looking for concordance in the diagnosis of organ-space surgical site infection

Interventions

Concordance between the two registers was analysed using Cohen´s Kappa.

Patients operated on rectal cancer, included in the Catalan Cancer RegistryPatients operated on rectal surgery, included in the Catalan Infection Surveillance Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated on rectal surgery for rectal cancer in Catalonia, Spain.

You may qualify if:

  • Patients \> 18 years old
  • Eligible patients with tumour ≤ 13 cm from anal verge, as measured by Magnetic Resonance Imaging
  • Primary adenocarcinoma
  • Oncological resection with curative intent
  • Cancer stages: I-II-III

You may not qualify if:

  • Transanal local resection
  • Emergency colorectal surgeries
  • Presence of metastases found in the diagnostic process or during the surgical procedure
  • Recurrence of the disease treated before the study period
  • Non-resectable tumour or palliative surgery
  • Patients operated in private centres

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Català d'Oncologia

L'Hospitalet de Llobregat, Barcelona, 08908, Spain

Location

Related Publications (1)

  • Matallana C, Pera M, Espin-Basany E, Biondo S, Badia JM, Limon E, Pujol M, de Lacy B, Aliste L, Borras JM, Manchon-Walsh P. Quality check: concordance between two monitoring systems for postoperative organ/space-surgical site infections in rectal cancer surgery. Linkage of data from the Catalan Cancer Plan and the VINCat infection surveillance programme. World J Surg Oncol. 2024 May 25;22(1):138. doi: 10.1186/s12957-024-03410-9.

MeSH Terms

Conditions

Rectal NeoplasmsSurgical Wound Infection

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesWound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2023

First Posted

October 27, 2023

Study Start

January 1, 2011

Primary Completion

December 31, 2016

Study Completion

July 30, 2023

Last Updated

May 31, 2024

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

: Restrictions apply to the availability of these data, which belong to two national databases and are not publicly available. Data was obtained from the Catalan Cancer Plan and VINCat, and are only available with the permission of their Technical Committees.

Locations